Vimarsana
Biggest News Aggregation in the World

Page 3 - Lymph Node News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Lymph Node. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Lymph Node Today - Breaking & Trending Today

#VisualAbstract: Sentinel-node biopsy only is noninferior to completion of axillary lymph node dissection in breast cancer with sentinel-node metastases - Vimarsana News

#VisualAbstract: Sentinel-node biopsy only is noninferior to completion of axillary lymph node dissection in breast cancer with sentinel-node metastases

1. The hazard ratio for recurrence or death comparing sentinel node biopsy only to completion axillary lymph node dissection was non-significant (0.89) and below the noninferiority margin. 2. The overall survival rates at 5 years were similar between both groups, 92.9% vs 92%. Evidence Rating Level: 1 (Excellent) Study Rundown: Previous studies have challenged the necessity

Minimally invasive techniques fight colorectal cancer precursors - Vimarsana News

Minimally invasive techniques fight colorectal cancer precursors

Colorectal cancer (CRC) is the second most common cancer in the United States. This highlights the importance of early detection and treatment of precancerous lesions like large polyps. Endoscopy offers a minimally invasive approach to removing these polyps, reducing the need for traditional surgery.

Experimental Therapy Could Grow You Brand New Livers - Vimarsana News

Experimental Therapy Could Grow You Brand New Livers

Biotech company LyGenesis announced Tuesday that it has begun a phase II trial of its therapy designed to grow miniature livers inside a person’s lymph nodes.

For Pet's Sake: Lymphoma is one of the more common types of cancer - Vimarsana News

For Pet's Sake: Lymphoma is one of the more common types of cancer

Lymphoma is one of the more common types of cancer that I see in my middle age to older canine patients. As with humans, lymphoma is a cancer of the lymphatic s

Penn analysis shows low risk of secondary cancers following CAR T cell therapy - Vimarsana News

Penn analysis shows low risk of secondary cancers following CAR T cell therapy

The development of any type of second cancer following CAR T cell therapy is a rare occurrence, as found in an analysis of more than 400 patients treated at Penn Medicine, researchers from the Perelman School of Medicine at the University of Pennsylvania reported today in Nature Medicine.